Person—creatinine serum level, total micromoles per litre NN[NN]
Identifying and definitional attributes
|Metadata item type:||Data Element|
|Short name:||Creatinine serum level (measured)|
|Registration status:||Health, Standard 01/10/2008|
|Definition:||A person's serum creatinine level measured in micromoles per litre.|
|Data Element Concept:||Person—creatinine serum level|
Value domain attributes
|Maximum character length:||4|
|Unit of measure:||Micromole per litre (µmol/L)|
Data element attributes
Collection and usage attributes
|Guide for use:|
There is no agreed standard as to which units serum creatinine should be recorded in.
Note: If the measurement is obtained in mmol/L it is to be multiplied by 1000.
Measurement of creatinine should be carried out by laboratories, or practices, which have been accredited to perform these tests by the National Association of Testing Authority.
Serum creatinine can be used to help determine renal function. Serum creatinine by itself is an insensitive measure of renal function because it does not increase until more than 50% of renal function has been lost.
Serum creatinine together with a patient's age, weight and sex can be used to calculate glomerular filtration rate (GFR), which is an indicator of renal status/ function. The calculation uses the Cockcroft-Gault formula.
Creatinine is normally produced in fairly constant amounts in the muscles, as a result the breakdown of phosphocreatine. It passes into the blood and is excreted in the urine. Serum creatinine can be used to help determine renal function. The elevation in the creatinine level in the blood indicates disturbance in kidney function.
GFR decreases with age, but serum creatinine remains relatively stable. When serum creatinine is measured, renal function in the elderly tends to be overestimated, and GFR should be used to assess renal function, according to the Cockcroft-Gault formula:
GFR (ml/min) = (140 - age [yrs]) x body wt (kg) [x 0.85 (for women)]
An alternative formula is derived from the Modification of Diet in Renal Disease (MDRD) study and does not rely on knowledge of body weight:
GFR (ml/min/1.73m2) = 32788 x creatinine-1.154 (umol/L) x age-0.203 x (males: 1, females: 0.742).
To determine the degree of chronic renal impairment
GFR > 90ml/min - normal
GFR >60 - 90ml/min - mild renal impairment
GFR >30 - 60ml/min - moderate renal impairment
GFR 0 - 30 ml/min - severe renal impairment
Note: The above GFR measurement should be for a period greater than 3 months. GFR may also be assessed by 24-hour creatinine clearance adjusted for body surface area.
In general, patients with GFR < 30 ml/min are at high risk of progressive deterioration in renal function and should be referred to a nephrology service for specialist management of renal failure.
Patients should be assessed for the complications of chronic renal impairment including anaemia, hyperparathyroidism and be referred for specialist management if required.
Patients with rapidly declining renal function or clinical features to suggest that residual renal function may decline rapidly (ie. hypertensive, proteinuric (>1g/24hours), significant comorbid illness) should be considered for referral to a nephrologist well before function declines to less than 30ml/min. (Draft CARI Guidelines 2002. Australian Kidney Foundation). Patients in whom the cause of renal impairment is uncertain should be referred to a nephrologist for assessment.
Source and reference attributes
Cardiovascular Data Working Group
National Diabetes Data Working Group
|Origin:||Caring for Australians with Renal Impairment (CARI) Guidelines. Australian Kidney Foundation|
|Related metadata references:|
Supersedes Person—creatinine serum level, micromoles per litre NN[NN] Health, Superseded 01/10/2008
|Implementation in Data Set Specifications:|
All attributes +
Acute coronary syndrome (clinical) DSS Health, Superseded 01/09/2012
Acute coronary syndrome (clinical) DSS Health, Superseded 02/05/2013
Acute coronary syndrome (clinical) NBPDS 2013- Health, Standard 02/05/2013
Cardiovascular disease (clinical) DSS Health, Superseded 01/09/2012
Cardiovascular disease (clinical) NBPDS Health, Standard 17/10/2018
Cardiovascular disease (clinical) NBPDS Health, Superseded 17/10/2018